PCI Biotech Holding ASA Sustainability Reports
PCI Biotech Holding ASA is a biopharmaceutical enterprise specialized in development of intracellular drug delivery technologies. The company focuses on developing a photochemical-based technology designed to enhance therapeutic efficacy across areas such as gene therapy and cancer treatment.
Sector: Manufacturing
Country: Norway
Exchange: Oslo Børs
LEI: 5967007LIEEXZXFIGG77
FIGI: BBG001SKMH64
5 reports from 2020 to 2025
